Rocuronium Bromide Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Feb 15, 2023.

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9251-10
Dosage Form
Injection
Presentation
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10)
Initial Posting
Feb 15, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.